Buprenorphine, Subutex and Suboxone.

Basically, Buprenorphine, Subutex and Suboxone can be helpful in moderating withdrawal effects from opiate addiction.

In October 2002, the Food and Drug Administration (FDA) approved buprenorphine monotherapy product, Subutex®, and a buprenorphine/naloxone combination product, Suboxone®, for use in opioid addiction treatment.

Buprenorphine is an opioid partial agonist. This means that, although buprenorphine is an opioid, and thus can produce typical opioid agonist effects and side effects such as euphoria and respiratory depression, its maximal effects are less than those of full agonists like heroin and methadone. At low doses buprenorphine produces sufficient agonist effect to enable opioid-addicted individuals to discontinue the misuse of opioids without experiencing withdrawal symptoms.

The agonist effects of buprenorphine increase linearly with increasing doses of the drug until at moderate doses they reach a plateau and no longer continue to increase with further increases in dose—the “ceiling effect.” Thus, buprenorphine carries a lower risk of abuse, addiction, and side effects compared to full opioid agonists. In fact, in high doses and under certain circumstances, buprenorphine can actually block the effects of full opioid agonists and can precipitate withdrawal symptoms if administered to an opioid-addicted individual while a full agonist is in the bloodstream.

Welcome back!

Related posts:

1. The Anabolic Steroid Controversy, Are They Addictive? One question that a lot of people have asked is...
2. Prescription Pill Abuse: The Hidden Addiction Virtually every prescription pill medication presents some risk of undesirable...
3. Cocaine:Have You Or A Loved One Crossed The Line? Are you worried about a loved one’s or your own...
4. How Does Someone Become Addicted to Opiates? Long-term opiate use changes the way nerve cells work in...

Tagged as: Buprenorphine, Suboxone, Subutex